Derivative Instruments - Schedule of Fair Value of Outstanding Derivative Instruments Recorded in the Accompanying Consolidate Balance Sheet (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
Mar. 31, 2025	Dec. 31, 2024
Accrued liabilities
Derivative Instruments, Gain (Loss) [Line Items]
Outstanding derivative instruments amounts	$ 8,188	$ 0
Other current assets
Derivative Instruments, Gain (Loss) [Line Items]
Outstanding derivative instruments amounts	$ 0	$ 287

Amount of gain (loss) on derivative instrument designated and qualifying as fair value hedge included in assessment of hedge effectiveness, recognized in earnings.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 1A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480627/815-20-45-1A

Name:	us-gaap_DerivativeFairValueHedgeIncludedInEffectivenessGainLoss
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration